Top analysts kicked off ALAB coverage with an Outperform and a $375 target, signaling confidence in Astera Labs' growth prospects. ALAB traded around $223.27 on Wednesday, implying meaningful upside if the target proves achievable. Citi, meanwhile, began ATI coverage with a Buy and a $229 target, underscoring broader semis enthusiasm.
Astera is set to report Q3 results after the close as Scorpio X-Series ramps. The company guides Q3 revenue of $540–$560M and ~72% gross margin, with a long-term target of 78%. Focus also includes Q4 outlook and optical interconnect expansion; technically, the stock remains in an uptrend but must reclaim the 200-day SMA near $255 to extend the move.
Astera Labs (ALAB) logged a TradePulse Power Inflow on Oct 27, lifting shares from $269.83 to a $285.74 intraday high as buy interest surged. The move indicates immediate order-flow momentum and a possible near-term upside, but sustainability beyond today remains uncertain, limiting longer-term implications.
Astera Labs climbed about 7% as AI-driven demand boosted memory-interface plays, helping the Nasdaq 100 reach an intraday high. The broader AI rally lifted peers like MU and SNDK, while financials lagged on rising yields. If AI demand stays robust, ALAB could extend near-term gains as the sector maintains leadership.
Northland Capital Markets upgraded Astera Labs (ALAB) to Outperform with a $350 price target, prompting a stock rally. The catalyst may draw fresh money into ALAB and help re-rate shares tied to semiconductor demand, though the extent depends on follow-through and broader AI-chip cycles.
Friday's weaker payroll figures revived appetite for growth tech, as traders priced in a Fed pause next month. For ALAB, a growth-oriented name sensitive to rate expectations, near-term upside looks plausible if the macro environment remains accommodative; risks include inflation surprises and potential policy shifts that could cap multiple expansion.